Medicus Pharma Ltd. Issues Restricted Shares for $1.45M in Bonuses

What Happened
Medicus Pharma Ltd. announced on its September 11, 2026 Form 8-K that on September 4, 2026 it granted an aggregate of 8,529,412 restricted common shares to certain officers and employees. Recipients elected to forgo cash bonus payments (approximately $1.45 million total) and receive the share value instead, with each grant sized by dividing the forgone cash by $0.1705 per share (the Nasdaq closing price on September 3, 2026). No additional consideration was paid or received.

Key Details

• Aggregate cash bonuses forgone: approximately $1.45 million.
• Restricted Common Shares issued: 8,529,412 shares.
• Share price used to calculate grants: $0.1705 per share (Nasdaq close, Sept. 3, 2026).
• Issuance was exempt from registration under Section 4(a)(2) of the Securities Act (transaction by issuer not involving a public offering).

Why It Matters
This filing documents a non-cash compensation action by the company that increases the number of restricted common shares outstanding. For investors, the item is material as it reflects management and employee compensation aligned with equity rather than cash and has a direct effect on the company’s share base. The issuance was made under a statutory exemption (no public offering) and did not involve additional cash proceeds to the company.